Ortin Laboratories
Ortin Laboratories Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Ortin Laboratories
Start SIPOrtin Laboratories Investment Rating
-
Master Rating:
-
Ortin Laboratories has an operating revenue of Rs. 6.86 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of -6% needs improvement, ROE of -3% is poor and needs improvement. The company has a reasonable debt to equity of 16%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 65 which is a FAIR score but needs to improve its earnings, a RS Rating of 27 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 91 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 1 | 1 | 3 | 2 |
| Operating Expenses Qtr Cr | 1 | 1 | 2 | 3 |
| Operating Profit Qtr Cr | 1 | 0 | 0 | 0 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 0 | 0 | 0 | 0 |
Ortin Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 21.27
- 50 Day
- 22.21
- 100 Day
- 22.8
- 200 Day
- 23.58
- 20 Day
- 21.43
- 50 Day
- 22.64
- 100 Day
- 23.1
- 200 Day
- 23.01
Ortin Laboratories Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 21.2 |
| Second Resistance | 21.75 |
| Third Resistance | 22.2 |
| RSI | 33.98 |
| MFI | 63.64 |
| MACD Single Line | -0.6 |
| MACD | -0.72 |
| Support | |
|---|---|
| First Resistance | 20.2 |
| Second Resistance | 19.75 |
| Third Resistance | 19.2 |
Ortin Laboratories Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 16,794 | 984,632 | 58.63 |
| Week | 45,592 | 2,517,568 | 55.22 |
| 1 Month | 51,639 | 3,595,610 | 69.63 |
| 6 Month | 87,285 | 4,308,379 | 49.36 |
Ortin Laboratories Result Highlights
Ortin Laboratories Synopsis
NSE-Medical-Diversified
Ortin Laborator. belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 8.23 Cr. and Equity Capital is Rs. 8.13 Cr. for the Year ended 31/03/2022. Ortin Laboratories Ltd. is a Public Limited Listed company incorporated on 27/10/1986 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110TG1986PLC006885 and registration number is 006885.| Market Cap | 16 |
| Sales | 7 |
| Shares in Float | 0.68 |
| No of funds | 1 |
| Yield |
| Book Value | 1.48 |
| U/D Vol ratio | 2.8 |
| LTDebt / Equity | 16 |
| Alpha | -0.01 |
| Beta | 1.32 |
Ortin Laboratories
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 15.68% | 15.68% | 15.68% | |
| Foreign Portfolio Investors | ||||
| Individual Investors | 79.59% | 77.73% | 80.15% | |
| Others | 4.73% | 6.59% | 4.17% |
Ortin Laboratories Management
| Name | Designation |
|---|---|
| Mr. J R K Panduranga Rao | Chairman & Managing Director |
| Mr. S Murali Krishna Murthy | Managing Director |
| Mr. S Srinivas Kumar | WholeTime Director & CFO |
| Mr. G Venkata Ramana | Non Executive Director |
| Mr. Bh Satyanarayana Raju | Non Executive Director |
| Mr. S Balaji Venkateswarlu | Non Executive Director |
| Mr. B Gopal Reddy | Independent Director |
| Mr. Murali Krishna Rayaprolu | Independent Director |
| Ms. Pottur Sujatha | Independent Director |
Ortin Laboratories Forecast
Price Estimates
Ortin Laboratories FAQs
What is Share Price of Ortin Laboratories ?
Ortin Laboratories share price is ₹19 As on 26 March, 2023 | 11:08
What is the Market Cap of Ortin Laboratories ?
The Market Cap of Ortin Laboratories is ₹15.9 Cr As on 26 March, 2023 | 11:08
What is the P/E ratio of Ortin Laboratories ?
The P/E ratio of Ortin Laboratories is -46.4 As on 26 March, 2023 | 11:08
What is the PB ratio of Ortin Laboratories ?
The PB ratio of Ortin Laboratories is 1.5 As on 26 March, 2023 | 11:08